249 related articles for article (PubMed ID: 31102138)
21. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy.
Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J
Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293
[No Abstract] [Full Text] [Related]
23. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
24. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
[TBL] [Abstract][Full Text] [Related]
26. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study.
Mori K; Fukuda K; Asaoka H; Ueda T; Kunimatsu A; Okamoto Y; Nasu K; Fukunaga K; Morishita Y; Minami M
Radiology; 2009 May; 251(2):557-65. PubMed ID: 19251941
[TBL] [Abstract][Full Text] [Related]
30. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
[TBL] [Abstract][Full Text] [Related]
31. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
Minami Y; Kitai S; Kudo M
Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
[TBL] [Abstract][Full Text] [Related]
32. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
33. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
34. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
[TBL] [Abstract][Full Text] [Related]
35. Does hepatobiliary phase sequence qualitatively outperform unenhanced T1-weighted imaging in assessment of the ablation margin 24 hours after thermal ablation of hepatocellular carcinomas?
Takeyama N; Vidhyarkorn S; Chung DJ; Siripongsakun S; Kim HJ; Lu DS; Raman SS
Abdom Radiol (NY); 2016 Oct; 41(10):1942-55. PubMed ID: 27271219
[TBL] [Abstract][Full Text] [Related]
36. Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images.
Kim KW; Lee JM; Klotz E; Kim SJ; Kim SH; Kim JY; Han JK; Choi BI
AJR Am J Roentgenol; 2011 May; 196(5):W565-72. PubMed ID: 21512046
[TBL] [Abstract][Full Text] [Related]
37. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma.
Petit A; Hocquelet A; N'kontchou G; Varin E; Sellier N; Seror O; Sutter O
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):273-283. PubMed ID: 31673728
[TBL] [Abstract][Full Text] [Related]
38. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma.
Zhong-Zhen S; Kai L; Rong-Qin Z; Er-Jiao X; Ting Z; Ao-Hua Z; Shu-Fang Y; Xu-Qi H
Ultraschall Med; 2012 Dec; 33(7):E250-E255. PubMed ID: 23238803
[TBL] [Abstract][Full Text] [Related]
39. Preablation three-dimensional ultrasonography can predict therapeutic effect and local tumor progression after radiofrequency ablation for hepatocellular carcinoma.
Matsuki Y; Matono T; Koda M; Miyoshi K; Sugihara T; Okano JI; Isomoto H
Eur J Radiol; 2020 Dec; 133():109358. PubMed ID: 33126170
[TBL] [Abstract][Full Text] [Related]
40. Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study.
Han S; Lee JM; Lee DH; Yoon JH; Chang W
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1579-1596. PubMed ID: 34312690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
